论文部分内容阅读
目的:探讨心律平治疗新生儿心律失常的临床价值。方法:2005～2010年期间,该院诊治的80例心律失常患儿,随机分为对照组(间隔时间不相等的给药方式,心律平100～200 mg,每日3次)和观察组(间隔时间相等的给药方式,心律平100～200 mg,每8 h给药1次),每组各40例。心律平治疗28天后,对两组患者的总有效率和不良反应等指标进行观察和比较。结果:与对照组的总有效率(67.5%)相比,观察组的总有效率明显升高(95.0%),P<0.05,差异有统计学意义;与对照组患儿的不良反应率(25.0%)相比,观察组出现不良反应的比例明显降低(10.0%),P<0.05,差异有统计学意义。结论:心律平间隔时间相等的给药可明显提高新生儿心律失常的临床疗效,值得临床广泛推广。
Objective: To investigate the clinical value of heart rhythm in the treatment of neonatal arrhythmia. Methods: From 2005 to 2010, 80 children with arrhythmia diagnosed and treated in our hospital were randomly divided into control group (administration mode with unequal interval time, 100 ~ 200 mg of heart rate, 3 times daily) and observation group ( Interval of the same way of administration, heart rate 100 ~ 200 mg, administered once every 8 h), 40 cases in each group. After 28 days of treatment with cardioversion, the total effective rate and adverse reactions of two groups of patients were observed and compared. Results: The total effective rate (95.0%) in the observation group was significantly higher than that in the control group (67.5%), P <0.05, the difference was statistically significant. The adverse reaction rate 25.0%), the proportion of adverse reactions in the observation group was significantly lower (10.0%), P <0.05, the difference was statistically significant. Conclusion: The equal administration of ventricular arrhythmia can significantly improve the clinical efficacy of arrhythmia neonates, it is worth widely clinical promotion.